Scientists at the University of Göttingen developed antibodies for a therapy of Multiple Sclerosis (MS) and potentially Rheumatoid Arthritis. A dramatic in vivo improvement in the clinical score of mouse EAE has been observed. High therapeutic effect has been achieved in proof of concept experiments with primates.
Further Information: PDF
MBM ScienceBridge GmbH
Phone: (0551) 30724-151
Contact
Dr. Jens-Peter Horst
